India Tweaks Audio-Visual Norms For Trials
This article was originally published in Scrip
Executive Summary
India has tweaked requirements around audio-visual recording of the informed consent process for clinical trials, relaxing the rules a little for HIV and leprosy drugs, but industry claims that the revised norms lack clarity on certain key aspects.
You may also be interested in...
Indian Clinical Research Sector: Hope And Despair Amid Shutdowns
India's clinical research segment has had a rough time of late. Uncertainties, evolving regulations and compliance deviations have hurt the sector that is now scarred with firms downing the shutter, mistrust and constant speculation. Scrip spoke to a number of CROs who appear to have weathered the storm, but it seems the industry may not be out of the woods just yet.
India Ethical Guidelines For Research: Pertinent – But Less May Be More?
India's draft revised ethical guidelines for biomedical and health research involving human participants covers a raft of new and existing segments. It expands on "specialized" areas such as "informed consent" and "vulnerability" – complex and delicate issues in the Indian context - but some experts say that the multiplicity of "overlapping" rules and guidelines could complicate compliance efforts.
India Tweaks More Trial Rules But Can It Change The Narrative?
India has tweaked another set of trial rules including one that capped the number of trials per investigator as it seeks to clear the logjam of regulatory requirements that has been stifling the clinical research segment in the country. Much though could depend on actual implementation and it remains to be seen if such measures can alter the course of sector.